26.11.2020 • News

Arkema Starts Up Extra China Kynar Capacity

Arkema plans to start up its 50% expansion of Kynar fluoropolymer capacity at Changshu, China, next month. First commercial volumes will be supplied starting January 2021, the French specialty chemicals group said.

The investment in the extra polyvinylidene fluoride (PVDF) output was driven by strongly growing demand for lithium-ion batteries used in electric vehicles and consumer electronic devices, as well as energy storage. Arkema said the global lithium-ion market continues to expand at an accelerating pace and the project further consolidates its world-leading position in PVDF.

“Our unique global Kynar fluoropolymer production footprint enables us to support the growth of our customers with speed and versatility,” said Erwoan Pezron, senior vice president, high performance polymers.

Arkema last invested in additional Kynar capacity in April 2018, when it started up a 20% expansion at its plant in Calvert City, Kentucky, USA.

Author: Elaine Burridge, Freelance Journalist

Arkema will start up its Kynar fluoropolymer expansion in China next month....
Arkema will start up its Kynar fluoropolymer expansion in China next month. First commercial volumes will be supplied starting January 2021. The investment was driven by strongly growing demand for lithium-ion batteries used in electric vehicles and consumer electronic devices. (c) Arkema

Interview

The UK Chemical Supply Chain
Trade and Competitiveness

The UK Chemical Supply Chain

The CBA, led by CEO Tim Doggett, is steering the UK chemical supply chain through trade uncertainty, sustainability pressures and logistics challenges, as he explains in this interview with CHEManager.

From Catalogue to Collaboration

Enamine's Expert Insights Collection Is Free to Download
Enamine’s 35 Years of Advancing Drug Discovery

Enamine's Expert Insights Collection Is Free to Download

From catalogue to collaboration — explore 35 years of drug discovery breakthroughs, novel building blocks, and the science shaping tomorrow's medicines. Download your complimentary copy now.

most read